KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Sep 21, 2023 $12.57 $12.74 $12.16 $12.45 553 882
Sep 20, 2023 $12.89 $13.31 $12.62 $12.81 616 495
Sep 19, 2023 $12.65 $12.90 $12.41 $12.85 505 942
Sep 18, 2023 $12.76 $12.77 $12.34 $12.71 463 894
Sep 15, 2023 $12.96 $12.98 $12.30 $12.68 1 303 935
Sep 14, 2023 $13.10 $13.43 $12.83 $12.91 605 457
Sep 13, 2023 $13.31 $13.58 $12.93 $13.00 551 334
Sep 12, 2023 $13.00 $13.48 $13.00 $13.36 345 322
Sep 11, 2023 $12.67 $13.09 $12.39 $12.97 550 980
Sep 08, 2023 $12.66 $12.87 $12.36 $12.61 306 624
Sep 07, 2023 $12.42 $12.73 $11.99 $12.59 410 636
Sep 06, 2023 $12.84 $12.99 $12.35 $12.65 729 997
Sep 05, 2023 $13.48 $13.72 $12.76 $12.84 870 441
Sep 01, 2023 $13.13 $13.75 $12.97 $13.45 890 931
Aug 31, 2023 $13.12 $13.15 $12.80 $12.87 610 014
Aug 30, 2023 $12.84 $13.20 $12.77 $13.12 726 935
Aug 29, 2023 $12.95 $13.27 $12.77 $12.82 727 836
Aug 28, 2023 $13.10 $13.45 $12.85 $12.99 365 794
Aug 25, 2023 $13.38 $13.70 $12.93 $13.04 626 023
Aug 24, 2023 $14.25 $14.25 $13.27 $13.35 557 578
Aug 23, 2023 $14.01 $14.60 $14.01 $14.33 550 024
Aug 22, 2023 $14.25 $14.60 $13.70 $13.93 786 966
Aug 21, 2023 $14.00 $14.24 $13.70 $13.98 480 990
Aug 18, 2023 $14.36 $15.15 $14.02 $14.04 617 742
Aug 17, 2023 $15.01 $15.08 $14.44 $14.57 654 322
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT